We use in vitro and in vivo models to investigate the molecular mechanisms that underlie cell death after stroke and trauma, and assess novel strategies for neuroprotection. Our tools comprise a combination of in vivo imaging, pharmacology, and molecular cell biology. We seek to understand how perturbations in cell-cell and cell-matrix signaling mediate neurovascular dysfunction in brain injury and neurodegeneration.